New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
08:05 EDTBSXBoston Scientific's Synergy stent system reports strong performance data
Boston Scientific reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the Synergy Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System to the PROMUS Element Stent System. The primary clinical and angiographic endpoints of this non-inferiority study have already been published.
News For BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
08:52 EDTBSXCourt ruling likely to be positive for Boston Scientific, says Bernstein
Subscribe for More Information
January 23, 2015
14:02 EDTBSXJPMorgan reports 5.7% passive stake in Boston Scientific
January 22, 2015
07:31 EDTBSXBoston Scientific damages in case likely to be manageable, says Wells Fargo
Subscribe for More Information
05:47 EDTBSXStocks with implied volatility movement; BSX T
Stocks with implied volatility movement; Boston Scientific (BSX) 49, AT&T (T) 20 according to iVolatility.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use